Involvement of the central noradrenergic system in cholinergic stimulation of the pituitary-adrenal response

Journal of Physiology and Pharmacology

Volumn 49, Issue 2, 1998, Pages 285-292

  Bugajski, J ^a   Borycz, J ^a   Gadek Michalska, A ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Adrenergic receptor antagonists; Carbachol; Corticosterone; Hypothalamic noradrenaline; Noradrenergic neurotoxin DSP 4

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; CARBACHOL; CORTICOSTERONE; PRAZOSIN; PROPRANOLOL; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; CORTICOSTERONE RELEASE; DOSE RESPONSE; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NORADRENERGIC SYSTEM; RAT;

ADRENERGIC ANTAGONISTS; ANIMALS; BENZYLAMINES; CARBACHOL; CORTICOSTERONE; DOPAMINE; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; MALE; MUSCARINIC AGONISTS; NICOTINIC AGONISTS; NOREPINEPHRINE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC;

EID: 0031871790     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Calogero AE, Kamiliaris TC, Gomez MT et al. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. Endocrinology 1989; 125: 2445-2453.
2. Suda T, Yajima F, Tomori N et al. Stimulatory effect of acetylcholine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. Life Sci (1987; 40: 673-677.
3. Bugajski J, Ga+ (Combining ogonek)dek-Michalska A, Borycz J, Bugajski AJ, Głód R. Histaminergic components in carbachol-induced pituitary-adrenocortical activity. J Physiol Phamacol 1994; 45: 419-428.
4. Hasey G, Hanin I. Plasma corticosterone is increased and correlated with brain acetylcholine in physostigmine-but not in neostigmine-treated rats. Psychoneuroendocrinology 1990; 15: 357-369.
5. Egozi Y, Kloog Y, Fleminger G, Sokolovsky M. Acetylcholine in the rat pituitary: a possible humoral factor. Brain Res 1988; 475: 376-379.
6. Tago H, McGeer PL, Bruce G, Hersh LB. Distribution of choline acetyltransferase-containing neurons of the hypothalamus. Brain Res 1987; 415: 49-62.
7. Semba K, Fibiger HC. Organisation of central cholinergic systems. In: Progress in brain research, Vol. 79, A Nordberg, K Fuxe, B Holmstedt, Sundwall A (eds). New York Elsevier, 1989, pp. 37-63.
8. Barren SE, Hoover DB. Localization of acetylcholinesterase and choline acetyltransferase in the rat pituitary gland. Histochem J 1983; 15: 1087-1098.
9. Calogero AE, Galluci WT, Bernardini R, Saoutis C, Gold PW, Chrousos GP. Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. Neuroendocrinology 1988; 47: 303-308.
10. Reader TA, Jasper HH. Interaction between monoamines and other transmitters in cerebral cortex. In: Monoamine Innervation of cerebral cortex, Alan R. Liss (ed), New York, 1984, pp. 195-225.
11. Gotoh M, Hirooka Y, Tajima T, Iguchi A, Smythe GA. Adrenocorticotropin and growth hormone secretions after intracerebroventricular administration of neostigmine in rats: their relationship to hypothalamic monoaminergic neuronal activities. Brain Res 1994; 659: 259-262.
12. Takahashi A, Ishimaru H, Ikarashi Y, Maruyama Y. Intraventricular injection of neostigmine increases dopaminergic and noradrenergic nerve activities: hyperglycemic effects and neurotransmitters in the hypothalamus. Neurosci Lett 1993; 156: 54-56.
13. Engberg G, Svensson TH. Pharmacological analysis of a cholinergic receptor mediated regulation of brain norepinephrine neurons. J Neural Transm 1980; 49: 137-150.
14. Ga+ (Combining ogonek)dek-Michalska A, Turoń M, Bugajski J, Połczyńska-Konior G. Effects of systemic and intracerebroventricular phenylephrine and clonidine on corticosterone secretion in rats. Endocrinol Exp 1990; 24: 249-258.
15. Bugajski J, Ga+ (Combining ogonek)dek-Michalska A, Borycz J, Bugajski AJ. Central histaminergic mechanisms in the corticosterone response to clonidine. J Physiol Pharmacol 1993; 44: 303-312.
16. Bugajski J, Turoń M, Ga+ (Combining ogonek)dek-Michalska A, Borycz JA. Catecholaminergic regulation of the hypothalamic-pituitary-adrenocortical activity. J Physiol Pharmacol 1991; 42: 93-103.
17. 2-adrenoceptors and brain cholinergic stimulation in sinaortic denervated rats. Eur J Pharmacol 1994; 271: 9-16.
18. Martin JR. Mechanisms of the cardiovascular response to posterior hypothalamic nucleus administration of carbachol. J Cardiovascular Pharmacol 1996; 27: 891-900.
19. 2-adrenoceptors in rat brain after short-term DSP-4 lesioning. Eur J Pharmacol 1993; 249: 37-41.
20. Zhang X, Zuo DM, Yu PH. Neuroprotection by R(-) deprenyl and N-2-hexyl-N-methylpropargylamine on DSP-4, a neurotoxin, induced degeneration of noradrenergic neurons in the rat locus coeruleus. Neurosci Lett 1995; 186: 45-48.
21. Bugajski J, Ga+ (Combining ogonek)dek-Michalska A, Ołowska A, Borycz J, Głód R, Bugajski AJ. Adrenergic regulation of the hypothalamic-pituitary-adrenal axis under basal and social stress conditions. J Physiol Pharmacol 1995; 46: 297-312.